AHR
aryl
hydrocarbon receptor
This gene encodes a ligand-activated
transcription factor involved in the regulation of biological
responses to planar aromatic hydrocarbons. This receptor has
been shown to regulate xenobiotic-metabolizing enzymes such as
cytochrome P450. Its ligands included a variety of aromatic
hydrocarbons.
Gene Symbol
Gene Name
aryl hydrocarbon receptor
Synonyms
AhR, AHR,
EC Number
Species
Human
Chromosome Location
7p15
Orthologs
Mouse 32976
Rat 82233
Express
placenta; uncharacterized tissue; uterus;
muscle; blood; mammary gland; brain; mixed; colon; lung; eye;
stomach; liver; adipose tissue; embryonic tissue; prostate;
esophagus; vascular; small intestine; bone marrow; testis;
lymph node; skin; kidney; connective tissue; mouth; thymus;
trachea; bladder; parathyroid; cochlea; ascites; heart; whole
brain; nerve; pancreas; thyroid; dorsal root ganglion;
umbilical cord; tonsil; cranial nerve; bone; whole body
Restr
Expr
Sequence
Count
252
SwissProt
Cytoplasm. Nucleus. First cytoplasmic, upon
binding with ligand and interaction with a HSP90, it
translocates to the nucleus
Back
to Top
Back
to Top
Back
to Top
Back
to Top
Back
to Top
Back
to Top
MIMID
Type
Title
600253
gene
ARYL HYDROCARBON RECEPTOR; AHR
Back
to Top
Gene Symbol
Gene Name
Score
HTL2
hypotrichosis, localized, autosomal
recessive
37.414
HCA
hypercalciuria, absorptive
36.406
Dst
dystonin
31.741
CYP1A1
cytochrome P450, family 1, subfamily A,
polypeptide 1
28.736
CYP1B1
cytochrome P450, family 1, subfamily B,
polypeptide 1
21.264
CYP3A7
cytochrome P450, family 3, subfamily A,
polypeptide 7
21.117
CYP3A5
cytochrome P450, family 3, subfamily A,
polypeptide 5
21.069
CYP2A6
cytochrome P450, family 2, subfamily A,
polypeptide 6
20.668
CYP2A13
cytochrome P450, family 2, subfamily A,
polypeptide 13
20.628
Cyp1b1
cytochrome P450, family 1, subfamily b,
polypeptide 1
20.302
CYP1A2
cytochrome P450, family 1, subfamily A,
polypeptide 2
20.261
LOC498196
similar to Cytochrome P450 3A2 (CYPIIIA2)
(P450-PCN2) (P450/6-beta-A) (Testosterone
6-beta-hydroxylase)
20.173
Cyp3a3
cytochrome P450, subfamily 3A, polypeptide
3
20.172
CYP11B1
cytochrome P450, family 11, subfamily B,
polypeptide 1
20.154
CYP2C9
cytochrome P450, family 2, subfamily C,
polypeptide 9
20.135
CYP21A2
cytochrome P450, family 21, subfamily A,
polypeptide 2
20.052
LOC502310
similar to cytochrome P450 2B15
19.702
Cyp2b13
cytochrome P450, family 2, subfamily b,
polypeptide 13
19.701
CYP2B6
cytochrome P450, family 2, subfamily B,
polypeptide 6
19.126
Back
to Top
Name
CARCINOMA, HEPATOCELLULAR
BODY WEIGHT
INFECTION
HYPERPLASIA
INFLAMMATION
CARCINOMA
BRONCHIAL HYPERREACTIVITY
LIVER NEOPLASMS
DRUGS
STRESS
EOSINOPHILIA
NEOPLASMS, EXPERIMENTAL
PREGNANCY
TACHYCARDIA
HEPATITIS
NERVE
ASTHMA
HYPERSENSITIVITY
LIVER NEOPLASMS, EXPERIMENTAL
DISEASE MODELS, ANIMAL
Back
to Top
Name
ARYL HYDROCARBON HYDROXYLASES
ESTRADIOL
DIOXINS
ARNT PROTEIN, HUMAN
ETHOXYRESORUFIN
CYTOCHROME P-450 ENZYME SYSTEM
POLYCHLORINATED BIPHENYLS
RECEPTORS, DRUG
ALLERGENS
ARNT PROTEIN, MOUSE
OXYGENASES
CYTOCHROME P-450 CYP1A1
NUCLEAR PROTEINS
RECEPTORS, ARYL HYDROCARBON
OXIDOREDUCTASES
PYRENE
HYDROCARBONS
OVALBUMIN
ALPHA-NAPHTHOFLAVONE
CYP1B1
Back
to Top
Name
MEMBRANE
LUNG
TUMOR CELLS, CULTURED
CELLS
CELL LINE
CELLS, CULTURED
CARDIAC
MUSCLE
MICROSOMES, LIVER
KIDNEY
HEART
BLOOD
SERUM
NEURONS
MICROSOMES
CYTOSOL
TISSUE
LIVER
TISSUES
HYPOTHALAMUS
Back
to Top
Back
to Top
AHR_HUMAN
10
20
30
40
50
MNSSSANITY
ASRKRRKPVQ
KTVKPIPAEG
IKSNPSKRHR
DRLNTELDRL
60
70
80
90
100
ASLLPFPQDV
INKLDKLSVL
RLSVSYLRAK
SFFDVALKSS
PTERNGGQDN
110
120
130
140
150
CRAANFREGL
NLQEGEFLLQ
ALNGFVLVVT
TDALVFYASS
TIQDYLGFQQ
160
170
180
190
200
SDVIHQSVYE
LIHTEDRAEF
QRQLHWALNP
SQCTESGQGI
EEATGLPQTV
210
220
230
240
250
VCYNPDQIPP
ENSPLMERCF
ICRLRCLLDN
SSGFLAMNFQ
GKLKYLHGQK
260
270
280
290
300
KKGKDGSILP
PQLALFAIAT
PLQPPSILEI
RTKNFIFRTK
HKLDFTPIGC
310
320
330
340
350
DAKGRIVLGY
TEAELCTRGS
GYQFIHAADM
LYCAESHIRM
IKTGESGMIV
360
370
380
390
400
FRLLTKNNRW
TWVQSNARLL
YKNGRPDYII
VTQRPLTDEE
GTEHLRKRNT
410
420
430
440
450
KLPFMFTTGE
AVLYEATNPF
PAIMDPLPLR
TKNGTSGKDS
ATTSTLSKDS
460
470
480
490
500
LNPSSLLAAM
MQQDESIYLY
PASSTSSTAP
FENNFFNESM
NECRNWQDNT
510
520
530
540
550
APMGNDTILK
HEQIDQPQDV
NSFAGGHPGL
FQDSKNSDLY
SIMKNLGIDF
560
570
580
590
600
EDIRHMQNEK
FFRNDFSGEV
DFRDIDLTDE
ILTYVQDSLS
KSPFIPSDYQ
610
620
630
640
650
QQQSLALNSS
CMVQEHLHLE
QQQQHHQKQV
VVEPQQQLCQ
KMKHMQVNGM
660
670
680
690
700
FENWNSNQFV
PFNCPQQDPQ
QYNVFTDLHG
ISQEFPYKSE
MDSMPYTQNF
710
720
730
740
750
ISCNQPVLPQ
HSKCTELDYP
MGSFEPSPYP
TTSSLEDFVT
CLQLPENQKH
760
770
780
790
800
GLNPQSAIIT
PQTCYAGAVS
MYQCQPEPQH
THVGQMQYNP
VLPGQQAFLN
810
820
830
840
850
KFQNGVLNET
YPAELNNINN
TQTTTHLQPL
HHPSEARPFP
DLTSSGFL
Back
to Top
Key
From
To
Length
Description
propeptide
1
10
9
chain
11
848
837
domain
41
81
40
domain
111
181
70
domain
275
342
67
domain
348
386
38
DNA-binding region
13
40
27
compositionally biased region
600
640
40
sequence variant
517
517
0
P -> S
sequence variant
554
554
0
R -> K (in dbSNP:rs2066853)
sequence variant
570
570
0
V -> I (in dbSNP:rs4986826)
sequence variant
786
786
0
M -> V
mutagenesis site
381
381
0
V -> A Increases specific ligand
binding
mutagenesis site
381
381
0
V -> D Abolishes specific ligand
binding
mutagenesis site
381
381
0
V -> G No effect on specific ligand
binding
sequence conflict
191
191
0
E -> EG (in Ref. 6)
sequence conflict
340
341
1
MI -> SD (in Ref. 7)
sequence conflict
807
848
41
in Ref. 1)in Ref.
1)
Back
to Top
SwissProt
P35869 ;
EMBL
D16354 ;BAA03857.1, mRNA
EMBL
L19872 ;AAA16210.1, mRNA
EMBL
AC003075 ;-, NOT_ANNOTATED_CDS, Genomic_DNA
EMBL
BC069390 ;AAH69390.1, mRNA
EMBL
BC070080 ;AAH70080.1, mRNA
EMBL
U28063 ;AAA92082.1, Genomic_DNA
EMBL
U27656 ;AAA92082.1, JOINED, Genomic_DNA
EMBL
U27657 ;AAA92082.1, JOINED, Genomic_DNA
EMBL
U28060 ;AAA92082.1, JOINED, Genomic_DNA
EMBL
U28061 ;AAA92082.1, JOINED, Genomic_DNA
EMBL
U28062 ;AAA92082.1, JOINED, Genomic_DNA
EMBL
U28064 ;AAA92083.1, Genomic_DNA
EMBL
U28066 ;AAA92084.1, Genomic_DNA
EMBL
U28065 ;AAA92084.1, JOINED, Genomic_DNA
EMBL
D38044 ;BAA07235.1, Genomic_DNA
PIR
S59514 ;S59514
UniGene
Hs.171189;
IntAct
P35869 ;
TRANSFAC
T01795 ;
Ensembl
ENSG00000106546 ;Homo sapiens
KEGG
hsa:196;
HGNC
HGNC:348 ;AHR
MIM
600253 ;gene
LinkHub
P35869 ;
ArrayExpress
P35869;
RZPD-ProtExp
A0474;
RZPD-ProtExp
IOH36592;
GO
GO:0005634 ;C:nucleus, IDA:UniProtKB
GO
GO:0004879 ;F:ligand-dependent nuclear receptor
activity, IDA:UniProtKB
GO
GO:0005515 ;F:protein binding, IPI:IntAct
GO
GO:0003700 ;F:transcription factor activity,
IDA:MGI
GO
GO:0006915 ;P:apoptosis, TAS:UniProtKB
GO
GO:0007049 ;P:cell cycle, TAS:UniProtKB
GO
GO:0006355 ;P:regulation of transcription,
DNA-dependent, IDA:UniProtKB
GO
GO:0006950 ;P:response to stress, IDA:UniProtKB
GO
GO:0009410 ;P:response to xenobiotic stimulus,
IDA:UniProtKB
GO
GO:0006366 ;P:transcription from RNA polymerase
II promoter, IDA:UniProtKB
InterPro
IPR001092 ;HLH_basic
InterPro
IPR011598 ;HLH_DNA_bd
InterPro
IPR001610 ;PAC
InterPro
IPR000014 ;PAS
InterPro
IPR000700 ;PAS-assoc_C
InterPro
IPR013655 ;PAS_3
InterPro
IPR013767 ;PAS_fold
Pfam
PF00010 ;HLH, 1
Pfam
PF00989 ;PAS, 1
Pfam
PF08447 ;PAS_3, 1
SMART
SM00353 ;HLH, 1
SMART
SM00086 ;PAC, 1
SMART
SM00091 ;PAS, 2
PROSITE
PS50888 ;HLH, 1
PROSITE
PS50113 ;PAC, FALSE_NEG
PROSITE
PS50112 ;PAS, 1
Back
to Top